Twist Bioscience files prospectus supplement to register resale of shares to Invenra

Twist Bioscience Corp

Registers resale of shares issuable under Feb 11, 2026 Stock Purchase Agreement with Invenra Inc.
Prospectus supplement filed; Orrick opinion on validity attached as Exhibit 5.1.
No share count, value, or terms disclosed in this filing.
Procedural registration of existing resale rights; no new business activity reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.